Valuation: Balchem Corporation

Market Cap 5.78B 4.95B 4.63B 4.24B 7.96B 553B 8.06B 54.72B 21.34B 278B 21.7B 21.23B 919B P/E 2026 *
33.5x
P/E 2027 * 32.2x
Enterprise Value 5.81B 4.98B 4.66B 4.27B 8.01B 556B 8.11B 55.06B 21.47B 279B 21.83B 21.36B 924B EV / Sales 2026 *
5.14x
EV / Sales 2027 * 4.8x
Free-Float
99.53%
Yield 2026 *
0.65%
Yield 2027 * 0.72%
1 day+0.92%
1 week+1.55%
Current month+8.19%
1 month+11.83%
3 months+12.07%
6 months+5.83%
Current year+18.21%
1 week 176.54
Extreme 176.54
182
1 month 160.46
Extreme 160.455
182.06
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 65.37
Extreme 65.37
186.03
Manager TitleAgeSince
Chief Executive Officer 61 2015-04-27
Director of Finance/CFO 49 2019-02-03
Chief Tech/Sci/R&D Officer 56 2025-09-30
Director TitleAgeSince
Director/Board Member 63 2010-09-15
Chairman 61 2016-12-31
Director/Board Member 59 2015-09-14
Date Insider Type Main position Quantity % Market Cap.
2/11/26 Free

Director

870 0.0027%
2/11/26 Free

Director

870 0.0027%
2/11/26 Free

General Counsel

11,315 0.0349%
Change 5-day change 1-year change 3-year change Capi.($)
+0.92%+1.55%+9.79%+34.37% 5.78B
+0.05%+2.00%-0.74%+55.98% 78.95B
+0.21%-0.15%-4.78%+18.98% 37.62B
+1.01%-2.65%-2.44%-24.19% 37.19B
-0.09%-3.36%-10.69%+16.35% 24.19B
+0.84%-2.76%+24.44%+19.28% 22.66B
+4.47%+10.28%+76.75%+25.92% 23.41B
-0.09%-5.42%-40.37%-37.60% 18.68B
+6.75%+5.21%+76.11%-23.87% 16.9B
-0.73%-4.56%+3.52%+75.56% 14.26B
Average +1.33%+0.01%+13.16%+16.08% 27.96B
Weighted average by Cap. +0.99%+0.29%+8.59%+20.90%

Financials

2026 *2027 *
Net sales 1.13B 969M 907M 830M 1.56B 108B 1.58B 10.72B 4.18B 54.39B 4.25B 4.16B 180B 1.2B 1.02B 958M 877M 1.65B 114B 1.67B 11.32B 4.42B 57.47B 4.49B 4.39B 190B
Net income 175M 150M 140M 128M 241M 16.73B 244M 1.66B 646M 8.4B 657M 642M 27.8B 182M 156M 146M 134M 251M 17.44B 254M 1.73B 673M 8.76B 684M 669M 28.97B
Net Debt 35.51M 30.42M 28.46M 26.05M 48.9M 3.4B 49.54M 336M 131M 1.71B 133M 130M 5.65B -39.68M -33.99M -31.8M -29.11M -54.63M -3.8B -55.36M -376M -147M -1.91B -149M -146M -6.31B
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,379
Date Price Change Volume
26-08-21 US$181.28 +0.92% 137,885
26-08-20 US$179.63 -0.31% 139,606
26-08-19 US$180.19 +1.80% 131,055
26-08-18 US$177.00 -0.77% 169,671
26-08-17 US$178.38 -0.07% 108,621
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
181.28USD
Average target price
209.25USD
Spread / Average Target
+15.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock